Combination intermittent chemotherapy for patients with disseminated neuroblastoma.
D002395:Catecholamines / Q000652:urine; D002648:Child; D002675:Child, Preschool; D003404:Creatinine / Q000652:urine; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D009362:Neoplasm Metastasis; D009447:Neuroblastoma / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D011879:Radiotherapy Dosage; D014642:Vanilmandelic Acid / Q000652:urine; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D002395:Catecholamines; D014642:Vanilmandelic Acid; D014750:Vincristine; D003520:Cyclophosphamide; D003404:Creatinine; D003630:Daunorubicin